Project Grant R21EB037763
- This federal Project Grant award for $641,360 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop a digitally programmable and versatile radio frequency (RF) coil for ultra-high-field brain magnetic resonance imaging (MRI) at 7 Tesla. The award will support the creation of an "Any-Nucleus Distributed Active Programmable Transmit...
- This federal Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development and demonstration of a novel optimization framework for the design and simulation of radiofrequency (RF) coils used in magnetic resonance imaging (MRI). The $1,247,944 award to New York University School of Medicine aims to introduce a new...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded a $306,203 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Resonance Research Inc. The grant, awarded on September 1, 2024, supports the development of an advanced, digitally-controlled multiband shimming system for improved neuroimaging using high-field magnetic resonance imaging (MRI) scanners. The goal is to create a...
- This federal Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of an innovative magnetic resonance imaging (MRI) technology. The $391,875 award to The General Hospital Corporation, doing business as Massachusetts General Hospital, aims to address the flip angle inhomogeneity issue in high-field 7...
- This Cooperative Agreement award from the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) provides $808,070 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a novel head-neck imaging system for comprehensive neurological MRI exams at 7 Tesla. The project aims to create a 16-channel transmit/64-channel receive radiofrequency coil...
- This National Science Foundation (NSF) Project Grant award to New York University (NYU) under the Computer and Information Science and Engineering program (CFDA 47.070) aims to develop an advanced software tool that automates the design and optimization of electromagnetic (EM) systems, with a focus on improving the performance of magnetic resonance imaging (MRI) devices. The $1,164,641 award, effective from August 1, 2023 to July 31, 2026, will create a software pipeline that combines geometry...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $514,357 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the Massachusetts Institute of Technology (MIT) on June 1, 2025. The purpose of this grant is to support the development and prototype demonstration of a portable, liquid-helium-free 1-T/560-mm RT bore point-of-care MRI magnet. This innovative MRI technology is intended to...
- This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to significantly enhance quantitative magnetic resonance imaging (MRI) technology for in-vivo analysis of neurovascular structures and the early developing brain's response to perinatal stroke. The $511,583 award, with a project period from August 1, 2025 to May 31,...
- The federal Project Grant award R56EB033347, in the amount of $499,291.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The award will support the development of breakthrough technology to enable future compact, mid-field (0.7 Tesla) magnetic resonance imaging (MRI) systems, with the goal of improving accessibility and...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,161,839 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Wisconsin System for the project "MRI Technology for Greater Efficiency and Improved Value". The overall goal is to design technologies that improve the value of MRI by enhancing efficiency, accessibility, safety, and user experience. Key...
This $481,250 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports the development of an innovative RF coil array for magnetic resonance-guided focused ultrasound (MRGFUS) neuromodulation. The objective is to create a specialized RF coil that can improve signal-to-noise ratio and image quality for MRGFUS, which is a non-invasive therapeutic technique that combines MRI and focused ultrasound to treat neurological conditions. Key innovations include using an imbalanced current/capacitor distribution and irregular coil geometry to maintain high receive sensitivity even when the coil is displaced from the brain's center. This project will involve electromagnetic simulations, prototype fabrication, and performance testing, with the goal of enhancing the imaging quality to enable more precise and effective MRGFUS therapeutic interventions. The award period runs from September 1, 2025 to August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $481.3k | 7/31/25 |